Group One Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-705
| Closed | -$11.1K | – | 7704 |
|
|
2024
Q1 | $11.1K | Buy |
+705
| New | +$10.9K | ﹤0.01% | 5817 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$1.28K | – | 8387 |
|
|
2023
Q3 | $1.27K | Buy |
+100
| New | +$1.38K | ﹤0.01% | 7171 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | -$16 | – | 8444 |
|
|
2022
Q2 | $0 | Sell |
1
-12,829
| -100% | -$142K | ﹤0.01% | 8719 |
|
|
2022
Q1 | $119K | Sell |
12,830
-10,594
| -45% | -$90.1K | ﹤0.01% | 5330 |
|
|
2021
Q4 | $229K | Buy |
23,424
+20,732
| +770% | +$390K | ﹤0.01% | 4950 |
|
|
2021
Q3 | $91K | Sell |
2,692
-215
| -7% | -$6.86K | ﹤0.01% | 6003 |
|
|
2021
Q2 | $106K | Buy |
+2,907
| New | +$113K | ﹤0.01% | 5891 |
|
|
2021
Q1 | – | Sell |
-2,584
| Closed | -$120K | – | 8141 |
|
|
2020
Q4 | $147K | Buy |
+2,584
| New | +$153K | ﹤0.01% | 4296 |
|
|
2020
Q2 | – | Sell |
-2,607
| Closed | -$139K | – | 6299 |
|
|
2020
Q1 | $107K | Sell |
2,607
-9,330
| -78% | -$518K | ﹤0.01% | 3243 |
|
|
2019
Q4 | $743K | Buy |
11,937
+2,947
| +33% | +$140K | 0.01% | 2125 |
|
|
2019
Q3 | $305K | Buy |
+8,990
| New | +$266K | ﹤0.01% | 2753 |
|
|
2018
Q4 | – | Sell |
-900
| Closed | -$35K | – | 5536 |
|
|
2018
Q3 | $35K | Buy |
+900
| New | +$33.3K | ﹤0.01% | 4164 |
|
Other funds holding DCPH
Group One Trading's DCPH Position: Q2 2024 in Review
Group One Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 705 shares — an estimated $11.1K sold.
Group One Trading first reported a position in DCPH in Q3 2018 and held it in 12 quarters. The position peaked at $743K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Group One Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 705 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $11.1K.
- Group One Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
- Group One Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $743K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.